No headlines found.
ACCESS Newswire (Tue, 24-Mar 8:30 AM ET)
ACCESS Newswire (Wed, 18-Mar 8:30 AM ET)
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
ACCESS Newswire (Tue, 10-Feb 4:10 PM ET)
ACCESS Newswire (Wed, 28-Jan 4:15 PM ET)
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
Sonoma Pharmaceuticals trades on the NASDAQ stock market under the symbol SNOA.
As of April 1, 2026, SNOA stock price climbed to $2.43 with 82,468 million shares trading.
SNOA has a beta of 2.51, meaning it tends to be more sensitive to market movements. SNOA has a correlation of 0.16 to the broad based SPY ETF.
SNOA has a market cap of $4.21 million. This is considered a Sub-Micro Cap stock.
Last quarter Sonoma Pharmaceuticals reported $4 million in Revenue and -$.48 earnings per share. This beat revenue expectation by $19,000 and missed earnings estimates by -$.17.
In the last 3 years, SNOA traded as high as $30.40 and as low as $1.75.
The top ETF exchange traded funds that SNOA belongs to (by Net Assets): VXF.
SNOA has underperformed the market in the last year with a return of +11.0%, while the SPY ETF gained +18.5%. In the last 3 month period, SNOA fell short of the market, returning -33.2%, while SPY returned -3.6%. However, in the most recent 2 weeks SNOA has outperformed the stock market by returning +1.2%, while SPY returned -2.1%.
SNOA support price is $2.00 and resistance is $2.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNOA shares will trade within this expected range on the day.